SEARCH

SEARCH BY CITATION

References

  • 1
    Franklin EC. Immunopathology of the amyloid diseases. Hosp Pract 1980; 15:7077.
  • 2
    Glenner GG. Amyloid deposits and amyloidosis: The beta fibril- loses. N Engl J Med 1980; 302: 12831292, 1333–1343.
  • 3
    Gorevic PD, Franklin EC. Amyloidosis. Annu Rev Med 1981; 32:261271.
  • 4
    KJsilevsky R.. Amyloidosis: A familiar problem in the light of current pathogenetic developments. Lab Invest 1983; 49: 381390.
  • 5
    Husby G., Sletten K. Chemical and clinical classification of amyloidosis 1985. Scand J Immunol 1986; 23: 253265.
  • 6
    Buxbaum J. The amyloidoses: I. Biochemistry of the amyloid proteins. Lab Management 1987; 25: 3841.
  • 7
    Cohen AS, Connors LH. The pathogenesis and biochemistry of amyloidosis. J Pathol 1987; 151:110.
  • 8
    Westermark P., Johnson KH, Pitkanen P. Systemic amyloidosis: A review with emphasis on pathogenesis. Appl Pathol 1985; 3:5568.
  • 9
    Puchtler H., Sweat F., Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962; 10:355364.
  • 10
    Glenner GG, Eanes ED, Page DL. The relation of the properties of Congo red-stained amyloid fibrils to the beta conformation. J Histochem Cytochem 1972; 20:821826.
  • 11
    Cooper JH. Selective amyloid staining as a function of amyloid composition and structure: Histochemical analysis of the alkaline Congo red, standardized toluidine blue, and iodine methods. Lab Invest 1974; 31:232238.
  • 12
    Glenner GG, Eanes ED, Bladen HA, et al. Beta pleated sheet fibrils: A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 1974; 22: 1141 1158.
  • 13
    Wright JR, Calkins E., Humphrey RL. Potassium permanganate reaction in amyloidosis: A histologic method to assist in differentiating forms of this disease. Lab Invest 1977; 36:274281.
  • 14
    Van Rijswijk MH, Van Heusden CWGJ. The potassium permanganate method: A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice. Am J Pathol 1979; 97:4354.
  • 15
    Shirahama T., Skinner M., Cohen AS, et al. Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta-2 microglobulin. Lab Invest 1985; 53:705709.
  • 16
    Glenner GG, Ignaczak TF, Page DL. The inherited systemic amyloidoses and localized amyloid deposits. In: StanburyJB, WyngaardenJB, FredricksonDS, eds.. The Metabolic Basis of Inherited Disease. New York : McGraw-Hill, 1978; 13081339.
  • 17
    Glenner GG, Ein D., Eanes DD, et al. Creation of amyloid fibrils from Bence Jones proteins in vitro. Science 1971; 174: 712714.
  • 18
    Glenner GG, Terry WD, Isersky C. Amyloidosis: Its nature and pathogenesis. Semin Hematol 1973; 10:6586.
  • 19
    Glenner GG, Terry WD, Harada M., et al. Amyloid fibril proteins: Proof of homology with immunoglobulin light chains by sequence analysis. Science 1971; 172:11501151.
  • 20
    Solomon A., Frangione B., Franklin EC. Bence Jones proteins and light chains of immunoglobulins: Preferential association of the lambda VI subgroup of human light chains with amyloidosis AL (lambda). J Clin Invest 1982; 70:453460.
  • 21
    Gertz MA, Skinner M., Cohen AS, et al. Isolation and characterization of a kappa amyloid fibril protein. Scand J Immunol 1985; 22:245250.
  • 22
    Costa PP, Figueira AS, Bravo FR. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA 1978; 75:44994503.
  • 23
    Benson MD Partial amino acid sequence homology between an heredofamilial amyloid protein and human plasma prealbumin. J Clin Invest 1981; 67:10351041.
  • 24
    Cornwell GG, Westermark P., Natvig JB, et al. Senile cardiac amyloid: Evidence that fibrils contain a protein immunologically related to prealbumin. Immunology 1981; 44:447452.
  • 25
    Gejyo F., Yamada T., Odani S., et al. A new form of amyloid protein associated with chronic hemodilaysis was identified as beta-2 microglobulin. Biochem Biophys Res Commun 1985; 129:701706.
  • 26
    Connors LH, Shirahama T., Skinner M., et al. In vitro formation of amyloid fibrils from intact beta-2 microglobulin. Biochem Biophys Res Commun 1985; 131:10631068.
  • 27
    Grubb A., Jensson O., Gudmundson G., et al. Abnormal metabolism of gamma trace alkaline microprotein. N Engl J Med 1984;311:15471549.
  • 28
    Ghiso J., Pons-Estel B., Frangione B. Hereditary cerebral amyloid angiopathy: The amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases. Biochem Biophys Res Commun 1986; 136:548554.
  • 29
    Glenner GG, Wong CW. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120:885890.
  • 30
    Kang J., Lemaire HG, Untebeck A., et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 1987; 325:733736.
  • 31
    Kaye GC, Butler MG, D'Ardenne AJ, et al. Isolated atrial amyloid contains atrial natriuretic peptide: A report of six cases. Br Heart J 1986;56:317320.
  • 32
    Sletten K., Westermark P., Natvig JB. Characterization of amyloid proteins from medullary carcinoma of the thyroid. J Exp Med 1976; 143:993998.
  • 33
    Kubota T., Kuroda E., Yamashima T., et al. Amyloid formation in prolactinoma. Arch Pathol Lab Med 1986; 110:7275.
  • 34
    Mori H., Mori S., Saitoh Y., et al. Growth hormone-producing pituitary adenoma with crystal-like amyloid immunohisto-chemically positive for growth hormone. Cancer 1985; 55:96102.
  • 35
    Westermark P., Wilander E. Islet amyloid in type 2 (noninsulindependent) diabetes is related to insulin. Diabetologia 1983; 24:342346.
  • 36
    Johnson KH, Westermark P., Nilsson G., et al. Feline insular amyloid: Immunohistochemical and immunochemical evidence that the amyloid is insulin-related. Vet Pathol 1985; 22:463468.
  • 37
    Westermark P., Wernstedt C., O'Brien TD, et al. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 1987; 127:414417.
  • 38
    Breathnach SM. Amyloid and amyloidosis. J Am Acad Dermatol 1988; 18:116.
  • 39
    Higuchi K., Matsumura A., Hashimoto K., et al. Isolation and characterization of senile amyloid-related antigenic substance (SASSAM) from mouse serum. J Exp Med 1983; 158:16001614.
  • 40
    Benson MD, Dwulet FE, DiBartola SP. Identification and characterization of amyloid protein AA in spontaneous canine amyloidosis. Lab Invest 1985; 52:448452.
  • 41
    Westermark P., Johnson KH, Sletten K., et al. AA-amyloidosis in dogs: Partial amino acid sequence of protein AA and immunohistochemical cross-reactivity with human and cow AA-amyloid. Comp Biochem Physiol 1985; 82 211215.
  • 42
    DiBartola SP, Benson MD, Dwulet FE, et al. Isolation and characterization of amyloid protein AA in the Abyssinian cat. Lab Invest 1985;52:485489.
  • 43
    Westermark P., Johnson KH, Westermark GT, et al. Bovine amyloid protein AA: Isolation and amino acid sequence analysis. Comp Biochem Physiol 1986; 85B:609614.
  • 44
    Sletten K., Husebekk A., Husby G. The amino acid sequence of an amyloid fibril protein AA isolated from the horse. Scand J Immunol 1987; 26:7984.
  • 45
    Linke RP, Hoi PR, Gruys E., et al. Immunohistochemical identification and crossreactions of amyloid-A fibril protein in man and eleven other species. J Comp Pathol 1984; 94:339356.
  • 46
    Levin M., Franklin EC, Frangione B., et al. The amino acid sequence of a major non-immunoglobulin component of some amyloid fibrils. J Clin Invest 1972; 51: 2773 2776.
  • 47
    Maury CPJ. Reactive (secondary) amyloidosis and its pathogenesis. Rheumatol Int 1984; 5:17.
  • 48
    Gorevic PD, Cleveland AB, Franklin EC. The biologic significance of amyloid. Ann NY Acad Sci 1982; 389:380394.
  • 49
    Kushner I., Gewurz H., Benson MD. C-reactive protein and the acute phase response. J Lab Clin Med 1987 S7:739749.
  • 50
    Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins-(pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34:141212.
  • 51
    Lofberg H., Grubb A., Thysell H., et al. The prevalence of renal amyloidosis of the AA-type in a series of 1,158 consecutive autopsies. Acta Pathol Microbiol Immunol Scand 1987; 95A:297302.
  • 52
    Bland JH. Clinical incidence of renal amyloidosis in rheumatoid arthritis. J Maine Med Assoc 1965; 56:251254.
  • 53
    Slauson DO, Gribble DH, Russell SW. A clinicopathological study of renal amyloidosis in dogs, i Comp Pathol 1970; 80: 335343.
  • 54
    DiBartola SP, Tarr MJ, Parker AT, et al. Clinicopathologic findings in dogs with renal amyloidosis: 59 cases (1976 1986). J Am Vet Med Assoc (in press).
  • 55
    Cheville NF. Amyloidosis associated with cyclic neutropenia in the dog. Blood 1968; 31:111114.
  • 56
    Gregory RS, Machado EA, Jones JB. Animal model: Amyloidosis associated with canine cyclic hematopoiesis in the gray Collie dog. Am J Pathol 1977; 87:721724.
  • 57
    Albisser AM, McAdam KPWJ, Perlman K., et al. Unanticipated amyloidosis in dogs infused with insulin. Diabetes 1983; 32:10921101.
  • 58
    Bending JJ, Pickup JC, Rowe IF, et al. Continuous subcutaneous insulin infusion does not induce a significant acute phase response of serum amyloid A protein. Diabetologia 1985; 28:113115.
  • 59
    Maxie MG. The urinary system. In: JubbKVF, KennedyPC, PalmerN., eds.. Pathology of Domestic Animals. Orlando , FL : Academic Press, 1985; 368369.
  • 60
    Shaw DP, Gunson DE, Evans LH. Nasal amyloidosis in four horses. Vet Pathol 1987; 24:183185.
  • 61
    Murray M., Rushton A., Selman I. Bovine renal amyloidosis: A clinicopathological study. Vet Rec 1972; 90:210216.
  • 62
    Johnson R., Jamison K. Amyloidosis in six dairy cows. J Am Vet Med Assoc 1984; 185:15381543.
  • 63
    Winkelmann J., Veltmann E., Trautwein G., et al. Amyloidosis in chronic erysipelas polyarthritis in pigs. DTW 1979; 86:131138.
  • 64
    Farnsworth GA, Miller S. An unusual form of hepatic amyloidosis in a goat. Vet Pathol 1985; 22:184186.
  • 65
    Rings DM, Garry FB. Amyloidosis associated with paratuberculosis in a sheep. Comp Com Ed Pract Vet 1988; 10:381385.
  • 66
    Lucke VM, Hunt VM. Interstitial nephropathy and papillary necrosis in the domestic cat. J Pathol Bacteriol 1965; 89:723728.
  • 67
    Clark L., Seawright AA. Generalised amyloidosis in seven cats. Pathol Vet 1969;6:117134.
  • 68
    Chew DJ, DiBartola SP, Boyce JT, et al. Renal amyloidosis in related Abyssinian cats. J Am Vet Med Assoc 1982; 181:139142.
  • 69
    Boyce JT, DiBartola SP, Chew DJ, et al. Familial renal amyloidosis in Abyssinian cats. Vet Pathol 1984; 21:3338.
  • 70
    Cohen AS, Shirahama T. Animal model: Spontaneous and induced amyloidosis. Am J Pathol 1972; 68:441444.
  • 71
    Skinner M., Shirahama T., Benson MD, et al. Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest 1977; 36:420427.
  • 72
    Ho FCS, Fu KH. A new model of A Aamyloidosis induced by oral pristane in BALB/c mice. Br J Exp Pathol 1987; 68:413420.
  • 73
    Sletten K., Husby G. The complete amino acid sequence of nonimmunoglobulin amyloid fibril protein AS in rheumatoid arthritis. Eur J Biochem 1974;41:117125.
  • 74
    Hermodson MA, Kuhn RW, Walsh KA, et al. Amino acid sequence of monkey amyloid protein A. Biochemistry 1972; 11:29342938.
  • 75
    Waalen K., Sletten K., Husby G., et al. The primary structure of amyloid fibril protein AA in endotoxininduced amyloidosis of the mink. Eur J Biochem 1980; 104:407412.
  • 76
    Benson MD, DiBartola SP, Dwulet FE. A unique insertion in the primary structure of bovine amyloid AA protein. J Lab Clin Med (in press).
  • 77
    Brandwein SR, Skinner M., Cohen AS. Isolation and characterization of spontaneously occurring amyloid fibrils in aged Syrian (golden) hamsters. Fed Proc 1981; 40:789.
  • 78
    Skinner M., Cathcart ES, Cohen AS, et al. Isolation and identification by sequence analysis of experimentally induced guinea pig amyloid fibrils. J Exp Med 1974; 140:871876.
  • 79
    Eriksen N., Ericsson LH, Pearsall N., et al. Mouse amyloid protein A: Homology with nonimmunoglobulin protein of human and monkey amyloid substance. Proc Natl Acad Sci USA 1976; 73:964967.
  • 80
    Dwulet FE, Benson MD. Primary structure of amyloid fibril protein AA in azocaseininduced amyloidosis in CBA/J mice. J Lab Clin Med 1987; 110:322329.
  • 81
    Gorevic PD, Greenwald M., Frangione B., et al. The amino acid sequence of duck amyloid A (AA) protein. J Immunol 1977; 118:11131118.
  • 82
    Ericsson LH, Eriksen N., Walsh KA, et al. Primary structure of duck amyloid protein A: The form deposited in tissues may be identical to its serum precursor. FEBS Lett 1987; 218:1116.
  • 83
    McAdam KPWJ, Li J., Knowles J., et al. The biology of SAA: Identification of the inducer, in vitro synthesis, and heterogeneity demonstrated with monoclonal antibodies. Ann NY Acad Sci 1982;389:126136.
  • 84
    Sipe JD, Ignaczak TF, Pollack PS, et al. Amyloid fibril protein AA: Purification and properties of the antigenically-related serum component as determined by solid phase radioimmunoassay. J Immunol 1976; 116:11511156.
  • 85
    Rosenthal CJ, Franklin EC, Frangione B., et al. Isolation and partial characterization of SAA: An amyloid-related protein from human serum. J Immunol 1976; 116:14151418.
  • 86
    Husebekk A., Skogen B., Husby G., et al. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 1985; 21: 283287.
  • 87
    Baltz ML, Rowe IF, Caspi D., et al. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils Clin Exp Immunol 1986; 66:701708.
  • 88
    Husebekk A., Skogen B., Husby G. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Scand J Immunol 1987; 25:375381.
  • 89
    Benditt EP, Hoffman JS, Eriksen N. SAA, an apoprotein of HDL: Its structure and function. Ann NY Acad Sci 1982; 389:183189.
  • 90
    Benson MD, Cohen AS. Serum amyloid A protein in amyloidosis, rheumatic, and neoplastic diseases. Arthritis Rheum 1979;22:3642.
  • 91
    Raynes JG, Cooper EH. Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease. J Clin Pathol 1983; 36:798803.
  • 92
    Eriksen N., Benditt EP. Trauma, high density lipoproteins, and serum amyloid protein A. Clin Chim Acta 1984; 140:139149.
  • 93
    Maury CPJ. Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin Sci 1985; 68:233238.
  • 94
    Biran H., Friedman N., Neumann L., et al. Serum amyloid A (SAA) variations in patients with cancer: Correlation with disease activity, stage, primary site, and prognosis. J Clin Pathol 1986; 39:794797.
  • 95
    Shainkin-Kestenbaum R., WinikoffY, Cristal N. Serum amyloid A concentrations during the course of acute ischaemic heart disease. J Clin Pathol 1986; 39:635637.
  • 96
    Sipe JD, Vogel SN, Sztein MB, et al. The role of interleukin-1 in acute phase serum amyloid A (SAA) and serum amyloid P (SAP) biosynthesis. Ann NY Acad Sci 1982; 389:137150.
  • 97
    Benson MD, Scheinberg MA, Shirahama T., et al. Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J Clin Invest 1977; 59:412417.
  • 98
    Maury CPJ, Teppo AM, Eklund B., et al. Serum amyloid A protein: A sensitive indicator of renal allograft rejection in humans. Transplantation 1983; 36:501504.
  • 99
    Maury CPJ, Hockerstedt K., Teppo AM, et al. Changes in serum amyloid A protein and beta-2 microglobulin in association with liver allograft rejection. Transplantation 1984; 38:552554.
  • 100
    Sipe JD, Vogel SN, Ryan JL, et al. Detection of a mediator derived from endotoxinstimulated macrophages that induces the acute phase serum amyloid A response in mice. J Exp Med 1979; 150:597606.
  • 101
    Benson MD, Kleiner E. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein. J Immunol 1980; 124:495499.
  • 102
    Benson MD. In vitro synthesis of the acute phase reactant SAA by hepatocytes. Ann NY Acad Sci 1982; 389:116120.
  • 103
    Tatsuta E., Shirahama T., Sipe JD, et al. Kinetics of SAP and SAA production by cultured mouse liver cells. Ann NY Acad Sci 1982;389:467470.
  • 104
    Hoffman JS, Benditt EP. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture. J Biol Chem 1982; 257:1051810522.
  • 105
    Sipe JD, Colten HR, Goldberger G., et al. Human serum amyloid A (SAA): Biosynthesis and postsynthetic processing of pre SAA and structural variants defined by complementary DNA. Biochemistry 1985;24:29312936.
  • 106
    Shirahama T., Skinner M., Cohen AS. Heterogenous participation of the hepatocyte population in amyloid protein AA synthesis. Cell Biol Int Rep 1984; 8:849856.
  • 107
    Shirahama T., Cohen AS. Immunocytochemical study of hepatocyte synthesis of amyloid AA. Am J Pathol 1985; 118:108115.
  • 108
    Miura K., Takahashi Y., Shirasawa H. Immunohistochemical detection of serum amyloid A protein in the liver and the kidney after casein injection. Lab Invest 1985; 53:453463.
  • 109
    Takahasi M., Yokota T., Yamashita Y., et al. Ultrastructural evidence for the synthesis of serum amyloid A protein by murine hepatocytes. Lab Invest 1985; 52:220223.
  • 110
    Coetzee GA, Strachan AF, van der Westhuyzen DR, et al. Serum amyloid A-containing human high density lipoprotein 3. J Biol Chem 1986;261:96449651.
  • 111
    Parks JS, Rudel LL. Alteration of high density lipoprotein subfraction distribution with induction of serum amyloid A protein (SAA) in the nonhuman primate. J Lipid Res 1985; 26:8291.
  • 112
    Hoffman JS, Benditt EP. Changes in high density lipoprotein content following endotoxin administration in the mouse. J Biol Chem 1982;257:1051010517.
  • 113
    Lowell CA, Stearman RS, Morrow JF. Transcriptional regulation of serum amyloid A gene expression. J Biol Chem 1986; 261:84538461.
  • 114
    Lowell CA, Potter DA, Stearman RS, et al. Structure of the murine serum amyloid A gene family. J Biol Chem 1986; 261:84428452.
  • 115
    Yamamoto KI, Goto N., Kosaka J., et al. Structural diversity of murine serum amyloid A genes: Evolutionary implications. J Immunol 1987; 139:16831688.
  • 116
    Bausserman LL, Herbert PN, McAdam KPWJ. Serum amyloid A polymorphism in a subject with a naturally occurring inflammatory response. Clin Chim Acta 1982; 118:201207.
  • 117
    Bausserman LL, Saritelli AL, Herbert PN, et al. NH2-terminal analysis of four of the polymorphic forms of human serum amyloid A proteins. Biochim Biophys Acta 1982; 704:556559.
  • 118
    Kluve-Beckerman B., Naylor SL, Marshall A., et al. Localization of human SAA gene(s) to chromosome 11 and detection of DNA polymorphisms. Biochem Biophys Res Commun 1986; 137: 11961204.
  • 119
    Kluve-Beckerman B., Long GL, Benson MD. DNA sequence evidence for polymorphic forms of human serum amyloid A (SAA). Biochem Genet 1986; 24: 795803.
  • 120
    Maury CPJ, Ehnholm C., Lukka M. Serum amyloid A protein (SAA) subtypes in acute and chronic inflammation. Ann Rheum Dis 1985; 44: 711715.
  • 121
    Ramadori G., Sipe JD, Colten HR. Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J Immunol 1985; 135:36453647.
  • 122
    Meek RL, Benditt EP. Amyloid A gene family expression in different mouse tissues. J Exp Med 1986; 164:20062017.
  • 123
    Fuks A., Zucker-Franklin D. Impaired Kupffer cell function pre- cedes development of secondary amyloidosis. J Exp Med 1985; 161:10131028.
  • 124
    Bausserman LL, Saritelli AL, Van Zuiden P., et al. Degradation of serum amyloid A by isolated perfused rat liver. J Biol Chem x 1987;262:15831589.
  • 125
    Baltz ML, Rowe IF, Caspi D., et al. Acute phase high density lipoprotein in the rat does not contain serum amyloid A protein. Biochem J 1987; 242:301303.
  • 126
    Hoffman JS, Benditt EP. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (ApoSAA), in the mouse. J Clin Invest 1983; 71:926934.
  • 127
    Benson MD, Aldo-Benson M. Effect of purified protein SAA on immune response in vitro: Mechanisms of suppression. J Immunol 1979; 122:20772082.
  • 128
    Aldo-Benson M., Benson MD. SAA suppression of immune response in vitro: Evidence of an effect on T cell-macrophage interaction. J Immunol 1982; 128:23902393.
  • 129
    Kaminski NE, Holsapple MP. Inhibition of macrophage accessory cell function in casein-treated B6C3F, mice. J Immunol 1987; 139:18041810.
  • 130
    Kisilevsky R., Boudreau L., Foster D. Kinetics of amyloid deposition: II. The effects of dimethylsulfoxide and colchicine therapy. Lab Invest 1983; 48: 6077.
  • 131
    Zemer D., Pras M., Sohar E., et al. Colchicine in the prevention and treatment of amyloidosis of familial Mediterranean fever. N Engl J Med 1986;314:10011005.
  • 132
    Brandwein SR, Sipe JD, Skinner M., et al. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Lab Invest 1985;52:319325.
  • 133
    Axelrad MA, Kisilevsky R., Willmer J., et al. Further characterization of amyloid-enhancing factor. Lab Invest 1982; 47:139146.
  • 134
    Kisilevsky R., Boudreau L. Kinetics of amyloid deposition: I. The effects of AEF and splenectomy. Lab Invest 1983; 48: 5359.
  • 135
    Niewold TA, Hoi PR, Van Andel ACJ, et al. Enhancement of amyloid induction by amyloid fibril fragments in hamster. Lab Invest 1987; 56:544549.
  • 136
    Ravid M., Shapira J., Lang R., et al. Prolonged dimethylsulfoxide treatment of 13 patients with systemic amyloidosis. Ann Rheum Dis 1982; 41:587592.
  • 137
    Kedar I., Greenwald M., Ravid M. Treatment of experimental murine amyloidosis with dimethylsulfoxide. Eur J Clin Invest 1977;7:149150.
  • 138
    Greenwald M., Kedar I., Sohar E. The effect of colchicine and dimethylsulfoxide (DMSO) on the genetic amyloidosis of the white Pekin duck. In: GlennerGG, CostaPP, FreitasF., eds. Amyloid and Amyloidosis. Amsterdam : Excerpta Medica, 1980; 584586.
  • 139
    Spyridakis L., Brown S., Barsanti J., et al. Amyloidosis in a dog: Treatment with dimethylsulfoxide. J Am Vet Med Assoc 1986; 189:690691.
  • 140
    Gruys E., Sijens RJ, Biewenga WJ. Dubious effect of dimethylsulfoxide (DMSO) therapy on amyloid deposits and amyloidosis. Vet Res Comm 1981; 5:2132.
  • 141
    Van Rijswijk MH, Ruinen L., Donker AJM, et al. Dimethylsulfoxide in the treatment of AA amyloidosis. Ann NY Acad Sci 1983; 389:6783.
  • 142
    Ravid M., Chen B., Berheim J., et al. Ascorbic acid induced regression of amyloidosis in experimental animals. Br J Exp Pathol 1985;66:137141.
  • 143
    Baltz ML, Caspi D., Glatthaar B., et al. The failure of ascorbic acid to alter the induction or remission of murine amyloidosis. Clin Exp Immunol 1984; 57:657662.
  • 144
    Baltz ML, Pepys MB, Moser U., et al. Effect of vitamin C dietary supplementation on survival in amyloidosis. Arthritis Rheum 1987;30:718719.
  • 145
    Woo P., O'Brien J., Robson M., et al. A genetic marker for systemic amyloidosis in juvenile arthritis. Lancet 1987; 2 (8562):767769.
  • 146
    Snow AD, Willmer J., Kisilevsky R. Sulfated glycosaminpglycans: A common constituent of all amyloids Lab Invest 1987;56:120123.
  • 147
    Snow AD, Kisilevsky R. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis: A histochemical study. Lab Invest 1985;53:3744.
  • 148
    Snow AD, Kisilevsky R., Stephens C., et al. Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Lab Invest 1987; 56:665675.
  • 149
    Linker A., Carney HC. Presence and role of glycosaminoglycans in amyloidosis. Lab Invest 1987; 57:297305.
  • 150
    Falck HM, Maury CPJ, Teppo AM, et al. Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J 1983; 286:13731456.
  • 151
    Hoffman JS, Ericsson LH, Eriksen N., et al. Murine tissue amyloid protein AA: NH2-terminal sequence identity with only one of two serum amyloid protein (apoSAA) gene products. J Exp Med 1984; 159:641646.
  • 152
    Yamamoto KI, Migita S. Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences. Proc Natl Acad Sci USA 1985; 82:29152919.
  • 153
    Meek RL, Hoffman JS, Benditt EP. Amyloidogenesis: One serum amyloid A isotype is selectively removed from the circulation. J Exp Med 1986; 163:499510.
  • 154
    Yamamoto KI, Shiroo M., Migita S. Diverse gene expression for isotypes of murine serum amyloid A protein during acute phase reaction. Science 1986; 232:227229.
  • 155
    Lavie G., Zucker-Franklin D., Franklin EC. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med 1978; 148:10201031.
  • 156
    Lavie G., Zucker-Franklin D., Franklin EC. Elastase-like proteases on the surface of human blood monocytes: Possible role in amyloid formation. J Immunol 1980; 125:175180.
  • 157
    Skinner M., Schneller SI, Connors LH, et al. Observations on the amyloid-degrading activity of serum and its relationship to human neutrophil elastase. Trans Assoc Am Physicians 1983; 96:437443.
  • 158
    Skinner M., Stone P., Shirahama T., et al. The association of an elastase with amyloid fibrils. Proc Soc Exp Biol Med 1986; 181:211214.
  • 159
    Teppo AM, Maury CPJ, Wegelius O. Characteristics of the amyloid A fibril-degrading activity of human serum. Scand J Immunol 1982; 16:309314.
  • 160
    Teppo AM, Maury CPJ. Do serine proteases degrade amyloid fibrils Scand J Immunol 1983; 18:363366.
  • 161
    Bausserman LL, Herbert PN. Degradation of serum amyloid A and apolipoproteins by serum proteases. Biochemistry 1984; 23:22412245.
  • 162
    Maury CPJ, Teppo AM. Mechanism of reduced amyloid-A-degrading activity of serum of patients with secondary amyloidosis. Lancet 1982; 2 (8292):234237.
  • 163
    Scott DL, Bracken P., Bacon PA, et al. Amyloid degrading factor activity: A non-specific calcium-mediated effect. Clin Sci 1985;68:333339.
  • 164
    Caspni D., Baltz ML, Feinstein A., et al. Does serum degrade amyloid fibrils? Failure to confirm enzymatic degradation of amyloid A fibrils as the basis of the so-called “amyloid degrading activity” of serum. In: GlennerGG, OssermanEF, BendittEP, et al., eds. Amyloidosis. New York : Plenum, 1986; 279284.
  • 165
    Benson MD. Pathogenesis of amyloidosis. In: ChewDJ, DiBartolaSP, eds. Seventh Annual Kal Kan Symposium for the Treatment of Small Animal Diseases. Vernon : Kal Kan Foods, 1984; 4752.
  • 166
    DiBartola SP, Tarr MJ. Corticotropin and thyrotropin response tests in Abyssinian cats with familial amyloidosis. J Am Anim Hosp Assoc 1988 (in press).
  • 167
    DiBartola SP, Tarr MJ, Benson MD. Tissue distribution of amyloid deposits in Abyssinian cats with familial amyloidosis. J Comp Pathol 1986;96:387398.
  • 168
    Blanchard JL, Baskin GB, Watson EA. Generalized amyloidosis in Rhesus monkeys. Vet Pathol 1986; 23:425430.
  • 169
    Shirahama T., Cohen AS. Ultrastructural studies of renal peritubular amyloid experimentally-induced in guinea pigs. Lab Invest 1968; 19:122131.
  • 170
    Hinton M., Lucke VM. Histological findings in amyloidosis of rabbits. J Comp Pathol 1982; 92:285294.
  • 171
    Hinton M., Lucke VM. Ultrastructural findings of the kidney in amyloidosis of rabbits. J Comp Pathol 1982; 92:295300.
  • 172
    Westermark P., Sletten K., Eriksson M. Morphologic and chemical variation of the kidney lesions in amyloidosis secondary to rheumatoid arthritis. Lab Invest 1979; 41:427431.
  • 173
    Westermark GT, Westermark P., Sletten K. Amyloid fibril protein AA: Characterization of uncommon subspecies from a patient with rheumatoid arthritis. Lab Invest 1987; 57:5764.